SYP-3343

Also Known As:

methyl (Z)-2-(2-((5-(4-chlorophenyl)-2-methylpyrazol-3-yl)oxymethyl)phenyl)-3-methoxyprop-2-enoate; methyl(E)-2-(2-((3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-yloxy) methyl)phenyl)-3-methoxyacrylate

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Chlorinated Hydrocarbons: 240
      - SYP-3343: 2
- Carboxylic Acids: 973
  - Acyclic Acids
    - Acrylates: 212
      - SYP-3343: 2
Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Pyrazoles: 61
      - SYP-3343: 2

Experts

1.	Chen, Guoliang: 1 article (01/2022)
2.	Hu, Tingzhang: 1 article (01/2022)
3.	Wang, Guixue: 1 article (01/2022)
4.	Wang, Mingxing: 1 article (01/2022)
5.	Zhu, Panpan: 1 article (01/2022)

Related Diseases

1.	Mitochondrial Diseases (Mitochondrial Disease) 01/01/2022 - "Adverse effects of SYP-3343 on zebrafish development via ROS-mediated mitochondrial dysfunction." 01/01/2022 - "These results indicated that SYP-3343 induced apoptosis accompanying reactive oxygen species-initiated mitochondrial dysfunction in zebrafish embryos."
2.	Angiodysplasia 04/01/2023 - "SYP-3343 inhibited zebrafish endothelial cell (zEC) migration, altered nuclear morphology, and triggered abnormal vasculogenesis and zEC sprouting angiogenesis, resulting in angiodysplasia. "

Related Drugs and Biologics

1.	Reactive Oxygen Species (Oxygen Radicals)